Compare BTCS & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BTCS | CBUS |
|---|---|---|
| Founded | 2008 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Agricultural Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 105.5M | 121.1M |
| IPO Year | 2008 | 2017 |
| Metric | BTCS | CBUS |
|---|---|---|
| Price | $1.20 | $1.27 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | $5.00 | ★ $9.00 |
| AVG Volume (30 Days) | ★ 660.3K | 271.3K |
| Earning Date | 05-13-2026 | 05-14-2026 |
| Dividend Yield | ★ 2.63% | N/A |
| EPS Growth | N/A | ★ 74.33 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $16,491,584.00 | $3,639,000.00 |
| Revenue This Year | $21.23 | $112.72 |
| Revenue Next Year | N/A | $83.18 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 304.85 | N/A |
| 52 Week Low | $1.07 | $1.09 |
| 52 Week High | $8.49 | $4.19 |
| Indicator | BTCS | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 34.07 | 41.44 |
| Support Level | N/A | $1.24 |
| Resistance Level | $1.98 | $1.51 |
| Average True Range (ATR) | 0.11 | 0.10 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 25.47 | 27.28 |
BTCS Inc. ("BTCS" or the "Company"), short for Blockchain Technology Consensus Solutions, is a U.S.-based Ethereum-first blockchain technology company committed to driving scalable revenue and ETH accumulation through its hallmark strategy, the DeFi/TradFi Accretion Flywheel, an integrated approach to capital formation and blockchain infrastructure. By combining decentralized finance ("DeFi") and traditional finance ("TradFi") mechanisms with its blockchain infrastructure operations, comprising NodeOps (staking) and Builder+ (block building), BTCS offers one of the most sophisticated opportunities for leveraged ETH exposure, driven by scalable revenue generation and a yield-focused ETH accumulation strategy. Discover how BTCS offers operational and financial leveraged exposure to Ethereum through the public markets at www.btcs.com.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.